SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 79 filers reported holding SERES THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 500 | -6.4% | 0.00% | – |
| Q4 2019 | $2,000 | -60.0% | 534 | -58.4% | 0.00% | – |
| Q3 2019 | $5,000 | 0.0% | 1,284 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | -44.4% | 1,284 | 0.0% | 0.00% | – |
| Q1 2019 | $9,000 | +80.0% | 1,284 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -50.0% | 1,284 | 0.0% | 0.00% | – |
| Q3 2018 | $10,000 | 0.0% | 1,284 | 0.0% | 0.00% | – |
| Q2 2018 | $10,000 | 0.0% | 1,284 | 0.0% | 0.00% | – |
| Q1 2018 | $10,000 | -33.3% | 1,284 | 0.0% | 0.00% | – |
| Q1 2017 | $15,000 | +15.4% | 1,284 | 0.0% | 0.00% | – |
| Q4 2016 | $13,000 | -13.3% | 1,284 | 0.0% | 0.00% | – |
| Q3 2016 | $15,000 | -6.2% | 1,284 | +140.4% | 0.00% | – |
| Q2 2016 | $16,000 | +14.3% | 534 | 0.0% | 0.00% | – |
| Q1 2016 | $14,000 | -22.2% | 534 | 0.0% | 0.00% | – |
| Q4 2015 | $18,000 | +12.5% | 534 | 0.0% | 0.00% | – |
| Q3 2015 | $16,000 | – | 534 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |